Kevin J. McNamara, President and CEO of Chemed Corporation (NYSE: CHE), filed a Form 4 on August 4, 2026, disclosing a stock option exercise and an open-market sale of Capital Stock occurring between July 31 and August 3, 2026.
Key Highlights
- Option exercise: McNamara acquired 2,001 shares of Capital Stock on July 31, 2026, via transaction code M, at an exercise price of $445.35 per share.
- Tax withholding disposal: 19,802 shares were disposed of on July 31, 2026, at $529.22 per share to cover the purchase price and tax obligation on the option exercise.
- Open-market sale: 2,000 shares were sold on August 3, 2026, at a weighted average price of $539.51, with individual sale prices ranging from $533.59 to $543.50.
- Remaining direct ownership: Following all reported transactions, McNamara directly beneficially owned 70,418 shares of Capital Stock.
- Derivative securities: The underlying stock option, with an exercise price of $445.35 and expiration date of October 28, 2026, had 264,158 derivative securities beneficially owned following the reported transaction.
- Option vesting: According to the filing, the option vests "in three equal annual installments commencing 10/28/2022."
McNamara's July-August 2026 Transactions in Chemed Capital Stock
According to the Form 4 filed with the SEC, McNamara first exercised a stock option on August 3, 2026 (transaction code M in Table II), converting 2,001 derivative securities into 2,001 shares of Capital Stock at the option's exercise price of $445.35. The corresponding Table I entry reflects the acquisition of those 2,001 shares on July 31, 2026, also at $445.35, bringing his direct beneficial ownership to 92,220 shares at that point.
On the same date, July 31, 2026, the filing records a disposal of 19,802 shares under transaction code F at $529.22 per share. The filing's footnote states this represented "Payment of purchase price and tax obligation on stock option exercise." After this disposal, direct beneficial ownership stood at 72,418 shares.
On August 3, 2026, the filing reports an open-market sale of 2,000 shares under transaction code S at a weighted average price of $539.51. The filing notes the shares were sold in multiple transactions at prices ranging from $533.59 to $543.50, and states that McNamara undertakes to provide full information on shares sold at each separate price upon request. Following this sale, his direct beneficial ownership totaled 70,418 shares. The filing was signed by Kevin J. McNamara on August 4, 2026.
What Was Disclosed
The filing disclosed three transactions in Chemed Corporation Capital Stock by President and CEO Kevin J. McNamara: a stock option exercise of 2,001 shares, a 19,802-share disposal for tax and purchase-price obligations, and a 2,000-share open-market sale, leaving direct ownership of 70,418 shares.



Please wait processing your request...